Loading
A phase 2 trial of JSKN016 and docetaxel in lung cancer, run by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, not yet recruiting.
Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical Study is a phase 2, randomised interventional study registered as NCT06775483 by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, with a registry enrolment figure of 220 participants, started 2025-01-17 and due to reach its primary completion in 2027-06-30. Interventions recorded: JSKN016; Docetaxel. Conditions listed: Advanced Non-small Cell Lung Cancer. Primary outcome: ORR assessed by the investigator per RECIST v1.1; Safety reflected by AE. Lung eligibility wording from the registry: "Histologically or cytologically confirmed locally advanced or metastatic non-small cell lung cancer (NSCLC) that is not suitable for radical surgery and/or radical radiotherapy, and meets one of the following conditions: EGFR sensitive mutations, and failed treatment with EGFR-TKI; Driver gene negat". No results are recorded here; the registry entry is the source.
Shares Alphamab Oncology, Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy, Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Docetaxel, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy, Non-small-cell lung cancer and the tag lung-deep-dive.